Shanghai Hengrui Pharmaceutical Co., Ltd.

This study tested an experimental drug called SHR-1707 in people with mild memory problems or mild Alzheimer's disease. The goal was to see if the drug could safely reduce harmful protein buildup in the brain. The trial was stopped early, so results are limited.

This study tested a new oral blood thinner (SHR2285) against a standard injection (enoxaparin) to prevent dangerous blood clots after total knee replacement. The trial planned to enroll 64 adults aged 40-75, but was terminated early. The goal was to see if the pill was as safe an…